Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    ml28442
Show Display Options
Rank Status Study
1 Recruiting STEAM: A Study of Sequential and Concurrent FOLFOXIRI/Avastin (Bevacizumab) Regimens Versus FOLFOX/Avastin in First-Line in Patients With Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: 5-fluorouracil;   Drug: bevacizumab [Avastin];   Drug: capecitabine [Xeloda];   Drug: fluoropyrimidine-based chemotherapy;   Drug: irinotecan;   Drug: leucovorin;   Drug: oxaliplatin

Indicates status has not been verified in more than two years